Discovery of Novel Biomarkers of Therapeutic Responses in Han Chinese Pemetrexed-Based Treated Advanced NSCLC Patients

Pemetrexed, one of the most commonly used drugs in advanced non–small cell lung cancer (NSCLC) therapies, often leads to various therapeutic responses in patients. These therapeutic responses to pemetrexed, including adverse drug reactions (ADRs) and its intended therapeutic effects, have been demon...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoqing, Zhang, Di, Huang, Lihua, Li, Guorong, Chen, Luan, Ma, Jingsong, Li, Mo, Wei, Muyun, Zhou, Wei, Zhou, Chenxi, Zhu, Jinhang, Wang, Zhanhui, Qin, Shengying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716463/
https://www.ncbi.nlm.nih.gov/pubmed/31507426
http://dx.doi.org/10.3389/fphar.2019.00944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716463/
https://www.ncbi.nlm.nih.gov/pubmed/31507426
http://dx.doi.org/10.3389/fphar.2019.00944

Ejemplares similares